Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting Transcript
The line is now open for the 2026 Annual Meeting of stockholders of Arrowhead Pharmaceuticals Inc.
Good morning and thank you for joining us today for our virtual meeting of the stockholders. I am Christopher Anzalone, the President, CEO and Chairman of the Board of Arrowhead Pharmaceuticals Incorporated, and will be serving as the Chairman for today's meeting.
Polls are open for voting. If you have a question, you may submit it via the meeting portal. With us today are Will Waddill, Lead Independent Director and Chair of the Audit Committee; Mauro Ferrari, Director; Hongbo Lu, Director; Mike Perry, Director and Chair of the Compensation Committee; Oye Olukotun, Director, Vicky Vakiener, Director; Dan Apel, Chief Financial Officer; and Patrick O'Brien, Chief Operating Officer and Corporate Secretary.
Also present are Ahmed Farid from KPMG, our independent registered public accounting firm. I hereby call this meeting to order. It has
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
